Zdravka Ognyanova Medarova, Ph.D.
Co-Author
This page shows the publications co-authored by Zdravka Medarova and Byung Hee Yoo.
Connection Strength
9.682
-
MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer. Sci Rep. 2021 02 02; 11(1):2844.
Score: 0.919
-
Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells. Sci Rep. 2020 02 06; 10(1):1970.
Score: 0.858
-
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer. PLoS One. 2019; 14(12):e0226356.
Score: 0.849
-
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy. Sci Rep. 2019 03 18; 9(1):4712.
Score: 0.806
-
Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin. PLoS One. 2018; 13(7):e0201046.
Score: 0.770
-
New Directions in the Study and Treatment of Metastatic Cancer. Front Oncol. 2018; 8:258.
Score: 0.769
-
Guidelines for Rational Cancer Therapeutics. Front Oncol. 2017; 7:310.
Score: 0.739
-
Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer. Sci Rep. 2017 03 21; 7:45060.
Score: 0.702
-
In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor. Mol Imaging Biol. 2016 Feb; 18(1):70-8.
Score: 0.649
-
Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer. Cancer Res. 2015 Oct 15; 75(20):4407-15.
Score: 0.632
-
Design of nanodrugs for miRNA targeting in tumor cells. J Biomed Nanotechnol. 2014 Jun; 10(6):1114-22.
Score: 0.578
-
Detection of miRNA expression in intact cells using activatable sensor oligonucleotides. Chem Biol. 2014 Feb 20; 21(2):199-204.
Score: 0.564
-
Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine. Cancers (Basel). 2022 Mar 21; 14(6).
Score: 0.248
-
Radiolabeling and PET-MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer. Cancer Nanotechnol. 2021; 12(1).
Score: 0.237
-
Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ. Mol Imaging Biol. 2014 Oct; 16(5):680-9.
Score: 0.148
-
Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model. Int J Cancer. 2013 Apr 15; 132(8):1860-7.
Score: 0.129
-
Magnetic resonance imaging of intra-pancreatic ductal nanoparticle delivery to islet cells. Diabetes Metab Res Rev. 2017 07; 33(5).
Score: 0.044
-
Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer. Int J Cancer. 2016 08 01; 139(3):712-8.
Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.